| Protocol Number |
Title |
2001LS058
|
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy |
2003CG061
|
AGCT0132 A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors |
2005LS023
|
MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors |
2005LS068
|
Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies |
2006CG060
|
ECOG 2805: ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma |
2006LS032
|
MT2005-21: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
2006NT007
|
Diagnostic Prostate Magnetic Resonance Imaging at 3 Tesla with an Endorectal Coil |
2006NT021
|
Secreted Biomarkers in Prostate Cancer Detection and Identification of Cancer Altered Proteins in Human Prostate Secretions |
2006UC048
|
Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer |
2007CG075
|
COG AREN0532: Treatment for Very Low, Low, and Secondary Risk Favorable Histology Wilms Tumor. |
2007NT080
|
Magnetic Resonance Imaging of the Prostate at 7 Tesla |
2007NT091
|
COG AREN03B2: Renal Tumors Classification, Biology and Banking Study. |
2008CG157
|
COG AREN0533 Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors |
2008IS063
|
A Phase 1b Study of LY573636-Sodium in Combination with Sunitinib Malate in Patients with Metastatic Renal Cancer |
2008IS066
|
Axitinib (AG-013736) as Second Line Therapy for Metastatic Renal Cell Cancer: Axis Trial |
2008IS072
|
A Multicenter, Randomized, Double-Blind, Phase 3 Study of Sunitinib Plus Prednisone versus Prednisone in Patients with Progressive Metastatic Hormone Refractory Prostate Cancer After Failure of a Docetaxel-Based Chemotherapy Regimen |
2008IS096
|
VEG108844 A Study of Pazopanib Versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma |
2008LS035
|
Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life |
2008LS043
|
Phase II Trial of Bortezomib and Rituximab for Patients with Post Transplant Lymphoproliferative Disorders (PTLD) MT2008-05R |
2009CG014
|
COG ADVL0821 A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, IND# 100947, NSC# 742460) in Children With Relapsed/Refractory Solid Tumors |
Clinical Trials Help